SCHEMBL2490797

SCHEMBL2490797

CCOc1ccccc1[C](c1ccccc1OCC)c1ccccc1OCC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.59
ALDH1A1 P00352 3/20 0.58
HPGD P15428 2/20 0.58
HSD17B10 Q99714 2/20 0.58
L3MBTL1 Q9Y468 3/20 0.52
GLA P06280 1/20 0.52
MAPT P10636 4/20 0.51
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.51
TSHR P16473 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
HTT P42858 1/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
RXFP1 Q9HBX9 1/20 0.48
KCNK3 O14649 1/20 0.47
KCNK9 Q9NPC2 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4363572 0.88 MEN1 (0.56) HCRTR1ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL4366694 0.88 MEN1 (0.56) HCRTR1ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL2117236 0.84 HCRTR1 (0.58) HCRTR1ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL6969031 0.83 HCRTR1 (0.66) HCRTR1ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL11763044 0.83 HCRTR1 (0.66) HCRTR1ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL2119940 0.83 HCRTR1 (0.56) HCRTR1ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL206583 0.83 HCRTR1 (0.66) HCRTR1ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL7666224 0.83 HCRTR1 (0.56) HCRTR1ALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL2492279 0.83 LMNA (0.53) HCRTR1ALDH1A1L3MBTL1MAPTNPSR1
SCHEMBL2494574 0.81 LMNA (0.60) ALDH1A1L3MBTL1MAPTMAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH HCRTR1 86/4885ALDH1A1 1292/4885HPGD 1749/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 HCRTR1 81/4885ALDH1A1 1031/4885HPGD 1563/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R HCRTR1 80/4885ALDH1A1 1187/4885HPGD 1618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.